Compare ENTA & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENTA | RVSB |
|---|---|---|
| Founded | 1995 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.5M | 110.2M |
| IPO Year | 2013 | 1993 |
| Metric | ENTA | RVSB |
|---|---|---|
| Price | $14.71 | $5.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $20.40 | $7.00 |
| AVG Volume (30 Days) | ★ 288.3K | 42.9K |
| Earning Date | 11-17-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 1.50% |
| EPS Growth | N/A | ★ 361.12 |
| EPS | N/A | ★ 0.22 |
| Revenue | ★ $65,324,000.00 | $52,756,000.00 |
| Revenue This Year | $0.99 | $10.25 |
| Revenue Next Year | $0.19 | $11.23 |
| P/E Ratio | ★ N/A | $24.23 |
| Revenue Growth | N/A | ★ 15.20 |
| 52 Week Low | $4.09 | $4.74 |
| 52 Week High | $15.34 | $6.59 |
| Indicator | ENTA | RVSB |
|---|---|---|
| Relative Strength Index (RSI) | 67.09 | 56.20 |
| Support Level | $13.75 | $5.01 |
| Resistance Level | $14.79 | $5.41 |
| Average True Range (ATR) | 0.74 | 0.15 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 90.89 | 82.50 |
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.